Example: Heart Attack

Search clinical trials for: Selegiline

Total 29 results

    • NCT01912391
      Completed
      Clinical Research Study to Evaluate Selegiline in the Treatment of Borderline Personality Disorder
      Conditions: Borderline Personality Disorder
    • NCT04586543
      Recruiting
      Clinical Trial of Selegiline Plus Docetaxel for the Treatment of Metastatic, Castrate-resistant Prostate Adenocarcinoma
      Conditions: Metastatic Castration-resistant Prostate Cancer; Adenocarcinoma of the Prostate
    • NCT00640159
      Completed
      Tolerability and Efficacy of Switch From Oral Selegiline to Orally Disintegrating Selegiline (Zelapar) in Patients With Parkinson's Disease
      Conditions: Parkinson's Disease
    • NCT00535262
      Terminated
      A Pilot Study Assessing EmSam in Bipolar Depression
      Conditions: Bipolar Depression
    • NCT01330030
      Completed
      Selegiline Patch for Treatment of Nicotine Dependence
      Conditions: Tobacco Use Disorder
    • NCT00443872
      Completed
      Efficacy of Orally Disintegrating Selegiline in Parkinson's Patients Experiencing Adverse Effects With Dopamine Agonists
      Conditions: Parkinson's Disease
    • NCT04130087
      Recruiting
      Selegiline and Reward Processing
      Conditions: Healthy
    • NCT00218517
      Completed
      Effectiveness of Selegiline in Treating Marijuana Dependent Individuals - 1
      Conditions: Marijuana Abuse
    • NCT00531947
      Completed
      Phase IV:Safety and Efficacy of EMSAM in Adolescents With Major Depression
      Conditions: Major Depressive Disorder
    • NCT00129311
      Completed
      Usefulness of Selegiline as an Aid to Quit Smoking - 1
      Conditions: Tobacco Use Cessation
    • NCT02225548
      Unknown status
      Sagene 2014 - Parkinson's Disease and Erectile Dysfunction
      Conditions: Parkinson's Disease; Erectile Dysfunction
    • NCT00000188
      Completed
      Selegiline in Treatment of Cocaine Dependence - 2
      Conditions: Cocaine-Related Disorders
    • NCT00439413
      Completed
      Selegiline for Smoking Cessation - 1
      Conditions: Nicotine Dependence
    • NCT00532116
      Completed
      PK Comparison of 6mg and 12mg EMSAM in Elderly vs. Non-Elderly
      Conditions: Healthy
    • NCT00456976
      Completed
      Efficacy of Selegiline in Negative Symptoms of Schizophrenia
      Conditions: Schizophrenia
    • NCT00032929
      Completed
      Selegiline Transdermal System for the Treatment of Cocaine Dependence - 1
      Conditions: Cocaine-Related Disorders
    • NCT00013585
      Completed
      Safety and Effectiveness of the Selegiline "Patch" for Decreased Mental Function in HIV Patients
      Conditions: Cognition Disorders; HIV Infections
    • NCT00000336
      Completed
      Selegiline in Outpatient Treatment for Cocaine Dependence - 1
      Conditions: Cocaine-Related Disorders
    • NCT00033072
      Unknown status
      Assessment of Potential Interactions Between Methamphetamine and Selegiline - 1
      Conditions: Amphetamine-Related Disorders
    • NCT00531596
      Completed
      Evaluation of Adhesion and Dermal Tolerability of EMSAM
      Conditions: Healthy
    • NCT01495195
      Completed
      Combined Donepezil and Selegiline Effects on Cocaine-Reinforced Behavior
      Conditions: Cocaine Use Disorders
    • NCT00285766
      Completed
      Safety, Tolerability and Efficacy of the Transdermal System in Elderly Subjects With Major Depression
      Conditions: Major Depression
    • NCT00002154
      Completed
      A Study of Thioctic Acid and Deprenyl in HIV-Infected Patients With Dementia
      Conditions: Cognitive Disorders; HIV Infections
    • NCT00027040
      Completed
      A Study of Decreased Mental Function Associated With HIV
      Conditions: Cognitive Disorders; HIV Infections
    • NCT00000337
      Completed
      Infusion Laboratory: Protocol 1 - Selegeline - 2
      Conditions: Cocaine-Related Disorders
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations